Video

The Changing Landscape of VTE Treatment

Publish date: May 21, 2014
Author(s):
Bauer K
Author and Disclosure Information

Watch as Kenneth A. Bauer, MD, discusses the new venous thromboembolism (VTE) oral agents and their impact on the future of care for patients with cancer.

 

For more presentations from the 9th Annual Meeting of the Association of VA Hematology/Oncology (AVAHO), click here: AVAHO Meeting Presentations

Next Article:

Prevention of Venous Thromboembolism After Total Joint Replacement: Rivaroxaban Update

Related Articles